"Disease mongering" y la epidemia de la depresiónuna revisión histórica del desarrollo del tratamiento psiquiátrico de la depresión y su relación con el proceso de promoción de enfermedades

  1. Alberto Monterde Fuertes
Revue:
Eikasía: revista de filosofía

ISSN: 1885-5679

Année de publication: 2022

Titre de la publication: Filosofía y Psicopatología

Número: 107

Pages: 57-92

Type: Article

DIALNET GOOGLE SCHOLAR lock_openAccès ouvert editor

D'autres publications dans: Eikasía: revista de filosofía

Résumé

Since the mid-twentieth century there has been a progressive increase in the incidence and prevalence of depression. Some authors analyzed this idea and considered that the evidence does not allow the current situation to be considered epidemic. The same authors consider several factors that are explanatory for the current situation. These possible explanations are like the characteristics of a disease mongering process, which is defined as widening the boundaries of treatable diseases to expand markets. I will show how a review of the historical development of psychiatry, in relation to these possible explanatory hypotheses, allows us to affirm that certain attitudes or situations could have promoted a process of disease mongering. However, due to limitations such as conceptual issues with the idea of disease mongering, a stronger claim cannot be realized.

Références bibliographiques

  • Abraham, John (2010), «Pharmaceuticalization of society in context: Theoretical, empirical and health dimensions», en Sociology, 44 (4), 603-622.
  • Abraham, John. (2008), «Sociology of pharmaceuticals development and regulation: a realist empirical research programme», en Sociology of Health & Illness, 30 (6), 869-885.
  • Álvarez, José María (2008), La invención de las enfermedades mentales. Madrid, Gredos.
  • Baxter, Amanda; Kate Scott; Alize Ferrari; Rosana Norman; Theo Vos y Harvey Whiteford (2014), «Challenging the myth of an “epidemic” of common mental disorders: Trehnds in the global prevalence of anxiety and depression between 1990 and 2010», en Depression and Anxiety, 31 (6), 1-11.
  • Caspi, Avshalom; Renate Houts; Antony Ambler; Andrea Danese et al. (2020), «Longitudinal Assessment of Mental Health Disorders and Comorbidities Across 4 Decades Among Participants in the Dunedin Birth Cohort Study», en JAMA Network Open, 3 (4), 203-221.
  • Castilla del Pinto, Carlos (2007), «Historia crítica de la psiquiatría en el siglo XX. Una mirada biográfica», en Revista de la Asociación Española de Neuropsiquiatría, 27 (1), 105-118.
  • Cohen, David y David Jacobs (2007), «Randomized controlled trials of antidepressants: clinically and scientifically irrelevant», en Debates in Neuroscience, 1, 44-54.
  • Cuijpers, Pim y Ioana Cristea (2015), «What if placebo effect explained all the activity of depression treatments?», en World Psychiatry, 14 (3), 310-311.
  • Foucault, Michel (1971), Madness and Civilisation. London, Travistock.
  • Frances, Allen (2014), ¿Somos todos enfermos mentales?: Manifiesto contra los abusos de la psiquiatría. Barcelona, Ariel.
  • González-Moreno, María; Cristian Saborido y David Teira (2015), «Disease-mongering through clinical trials», en Studies in History and Philosophy of Biological and Biomedical Sciences, 51, 11-18.
  • Healy, David (2014), «Shaping the intimate: Influences on the experience of everyday nerves», en Social Studies of Science, 34 (2), 219-245.
  • Healy, David (2004), The Creation of Psychopharmacology. Cambridge, Harvard University Press.
  • Healy, David (1987), «The structure of psychopharmacological revolutions», en Psychiatric Developments, 4, 349-376.
  • Hidaka, Brandon (2012), «Depression as a disease of modernity: Explanations for increasing prevalence», en Journal of Affective Disorders, 140 (3), 205-214.
  • Horwitz, Allan (2010), «How and age of anxiety became an age of depression», en The Milkank Quarterly, 88(1), 112-138.
  • Horwitz, Allan (2004), Creating mental illness. Chicago, The University of Chicago Press.
  • Horwitz, Allan y Jerome Wakefield (2007), The loss of sadness: How psychiatry transformed normal sorrow into depressive disorder. Nueva York, Oxford University Press.
  • Huertas, Rafael (2017), Psiquiatría y antipsiquiatría en el segundo franquismo y la transición.Madrid, Los Libros de la Catarata.
  • Illich, Ivan (1975), Némesis médica: la expropiación de la salud. Barcelona, Barral.
  • Jacob, Stanly y Vikram Patel (2014), «Classification of mental disorders: A global mental health perspective», en The Lancet, 383, 1143-1435.
  • Kaczmarek, Emila (2019), «How to distinguish medicalization from over-medicalization?», en Medicine, Health Care and Philosophy, 22, 119-228.
  • Kessler, Ronald; Wai Tat Chiu; Olga Delmer; Kathleen Merikangas y Ellen Walters (2005), «Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication», en Archives of General Psychiatry, 62 (6), 617-627.
  • Kirsch, Irving (2014), «Antidepressants and the placebo effect», en Zeitschrift fur Psychologie, 222 (3), 128-134.
  • Kirsch, Irving (2010), The emperor's new drugs: Exploding the antidepressant myth. New York, Basic Books.
  • Kirsch, Iirving; Brett Deacon; Tania Huedo-Medina; Alan Scoboria; Thomas Moore y Blair Jhonson (2008), «Initial severity and antidepressant Benefits: a meta-analysis of data submitted to the Food and Drug Administration», en PLoS Medicine, 5 (2), 260-268.
  • Kovess, Viviane et al. (2004), The state of mental health in the European Union. European Comission, https://ec.europa.eu/health/ph_projects/2001/monitoring/fp_monitoring_2001_frep_06_en.pdf [05/01/2022]
  • Liu, Qingqing; Hairong He; Jin Yang; Xiaojie Feng; Feng Zhao y Jun Lyu (2020), «Changes in the global burden of depression from 1990 to 2017: Findings from the Global Burden of Disease study», en Journal of Psychiatric Research, 126, 134-140.
  • Martín, Mar (2018), «La depresión, una epidemia silenciosa que recorre Portugal», en La Vanguardia, 25/09/2018 https://www.lavanguardia.com/politica/20180925/452029234598/la-depresion-unaepidemia-silenciosa-que-recorre-portugal.html [05/01/2022]
  • McInerney, Melissa; Jennifer Mellor y Lauren Hersch Nicholas (2013), «Recession depression: Mental healt effects of the 2008 stock market crash», en Journal of Health Economies, 32 (6), 1090-1104.
  • Millhouse, Todd y Joseph Porter (2015), «A brief history of the development of antidepressant drugs: from monoamines to glutamate», en Experimental and Clinical Psychopharmacology, 23(1), 1-21.
  • Moncrieff, Joanna (2013), Hablando claro: Una introduccion a los fármacos psiquiátricos. Barcelona, Herder.
  • Moncrieff, Joanna (2008), «The creation of the concept of an antidepressant: An historical analysis», en Social Science & Medicine, 66 (11), 2346-2355.
  • Mordor Intelligence (2020), «Antidepressant market: growth, trends, COVID-19 impact and forecast (2021-2026)», en Mordor Intelligence, https://www.mordorintelligence.com/industry-reports/antidepressants-market
  • Moyniham, Ray (2012), «Disease-mongering», en The Politics of Medicine (e-Encyclopedia) https://haiweb.org/encyclopaedia/disease-mongering/ [10/01/2022]
  • Moyniham, Ray y David Henry (2006), «The fight against disease mongering: generating knowledge for action, en PLOS Medicine, 3 (4), 425-428.
  • Moynihan, Roy; Ioana Heath y David Henry (2002), «Selling sickness: The pharmaceutical industry and disease mongering», en British Medical Journal, 324, 886-891.
  • Mulder, Roger (2008), «An epidemic of depression or the medicalization of distress?», en Perspectives in Biological Medicine, 51 (2), 238-250.
  • Olfson, Mark; Steven Marcus; Benjamin Druss; Lynn Elinson; Terri Tanielian y Harold Alan Pincus (2002), «National trends in the outpatient treatment of depression», en JAMA, 287 (2), 203-209
  • Parker, Gordon (2007), «Is depression overdiagnosed? Yes», en British Journal of Medicine, 335 (7615), 328-329.
  • Payer, Lynn (1992), Disease-mongers: How doctors, drug companies, and insurers are making you feel sick. Nueva York, Wiley and Sons.
  • Pérez Álvarez, Marino y Héctor González Pardo (2007), La invención de los trastornos mentales: ¿Escuchando al fármaco o al paciente? Madrid, Alianza.
  • Reid, Ian (2013), «Are antidepressants overprescibed? No», en British Medical Journal, 346.
  • Rose, Nikolas (2006), «Disorders without borders? The expanding scope of psychiatric practice», en BioSocieties, 1 (4), 465-484.
  • Sholl, Jonathan (2017), «The muddle of medicalization: patologizing or medicalizing?», en Theory of Medicine and Bioethics, 38 (4), 265-278.
  • Shorter, Edward (2008), Before prozac: The troubled history of mood disorders in psychiatry. Nueva York, Oxford University Press.
  • Shorter, Edward (1998), A History of Psychiatry: From the Era of the Asylum to the Age of Prozac. Hoboken, John Wiley & Sons.
  • Smith, Kerri (2014), «Mental health: a world of depression», en Nature, 515, 180-181.
  • Spence, Des (2013), «Are antridepressants overprescribed? Yes», en British Journal of Medicine, 346, 1-2.
  • Stucci-Portocarrero, Santiago (2017), «¿Realmente existe una “epidemia de depresión”?», en Revista de Neuropsiquiatría, 80 (4), 261-264.
  • Summerfield, Derek (2006), «Depression: epidemic of pseudo-epidemic?», en Journal of the Royal Society of Medicine, 99 (3), 161-162.
  • Vidal, Fernando y Francisco Ortega (2021), ¿Somos nuestro cerebro?: la construcción del sujeto cerebral. Madrid, Alianza.
  • Vigo, Daniel; Graham Thronicroft; Rifat Atun (2016), «Estimating the true global burden of mental illness», en Lancet Psyachiatry, 3 (2), 171-178.
  • Wakefield, Jerome (2015), «DSM-5, psychiatric epidemiology and the false positives problem», en Epidemiology of Psychiatric Science, 24 (3), 188-196.
  • Wakefield, Jerome y Steeves Demazeux (2016), Sadness or Depression?: International perspectives on the depression epidemic and its meaning. Amsterdam, Springer.
  • Williams, Simon; Paul Martin y Jonathan Gabe (2011), «The pharmaceuticalisation of society? A framework for analysis», e, Sociology of Health & Illness, 33 (5), 710-725.
  • Withaker, Robert (2018), Anatomia de una epidemia. Madrid, Capitán Swing.
  • World Health Organization (2020, enero 30), «Depression», en World Health Organization. https://www.who.int/news-room/fact-sheets/detail/depression [05/03/2021].
  • World Health Organization (2001), Mental health: New understanding, new hope. Ginebra, WHO.
  • Wright, Oliver (2016), «Teenagers struck by depression epidemic», en The Times https://www.thetimes.co.uk/article/teenagers-struck-by-depression-epidemic-gnc05fht8 [05/03/2021]
  • Wu, Tianchen; Xiaoqian Jia; Huifeng Shi; Jieqiong Niu; Xiaohan Yi; Jialei Xie y Xiaoli Wang (2021), «Prevalence of mental health problems during the COVID-19 pandemic: A systemtic review and meta-analysis», en Journal of Affective Disorders, 281, 91-98
La source de données: Dialnet